Remdesivir in a pregnant patient with COVID-19 pneumonia

• المؤلفون الرئيسيون: Ranadheer Dande (مؤلف), Anum Qureshi (مؤلف), Kia Persaud (مؤلف), Chahat Puri (مؤلف), Sajida Zulfiqar (مؤلف), Shankar Awasthi (مؤلف)
• التنسيق: كتاب
• منشور في: Greater Baltimore Medical Center, 2021-01-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non...